Melissa Schwartz, DO
Otolaryngology/Facial Plastic Surgery · Elkins Park, PANPI 1124005046
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Optinose US, Inc. accounts for 73.5% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $3,648 and has fallen 93.9% since, to $221 in 2024.
Across 62 payments — averaging $76.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$3K
- Intersect ENT, Inc.$189
- GSK$174
- Sanofi$157
- Medtronic$122
- Takeda Pharmaceuticals U.S.A., Inc.$115
- plus $502 from 10 others
What the payments were for
- Consulting fees$2,50053%
- Travel & lodging$3317%
- Food & beverage$1,89840%
- Education$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 14 | $3,492 |
| Intersect ENT, Inc. | 3 | $189 |
| GSK | 8 | $174 |
| Sanofi | 5 | $157 |
| Medtronic | 1 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $115 |
| CSL Behring | 5 | $106 |
| Regeneron Healthcare Solutions, Inc. | 5 | $105 |
| Alk-abello, Inc | 5 | $99 |
| Shire North American Group Inc | 3 | $43 |
| Aerin Medical Inc. | 3 | $42 |
| Arbor Pharmaceuticals, Inc. | 2 | $37 |
| Merck | 1 | $22 |
| Kaleo, Inc. | 1 | $18 |
| Greer Laboratories, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$3,138
How this compares
$4,751 in reported general payments places this provider in the 85th percentile of 21 otolaryngology/facial plastic surgery providers in Pennsylvania.
See all otolaryngology/facial plastic surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XhanceFluticasone Propionate | 16 | $9,883 |
| Fluticasone Propionate | 261 | $3,931 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 27 | $3,127 |
| Ipratropium Bromide | 56 | $1,063 |
| Azelastine Hcl | 37 | $846 |
| Levocetirizine Dihydrochloride | 32 | $437 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $361 |
| Omeprazole | 25 | $298 |
| Montelukast Sodium | 16 | $267 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 16 | $194 |
| Mometasone Furoate | 16 | $189 |
| Famotidine | 36 | $152 |
| Methylprednisolone | 20 | $151 |
| Prednisone | 26 | $129 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $3,492 | $9,88316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 21 otolaryngology/facial plastic surgery providers in Pennsylvania.
Other otolaryngology/facial plastic surgery in Elkins Park
- Jason BloomBryn Mawr$718K
- Donald SessoNorristown$23K
- Sean CarrollErie$6K
- Adam MariottiExton$5K
- Jeffrey BrigliaLanghorne$4K
- Aykut UnsalPhiladelphia$4K
- Michael PicarielloExton$4K
- Raphael GabayPhiladelphia$4K
- Jose UribeBethlehem$4K
- Harleen SethiPhiladelphia$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.